Addlife redovisade en omsättningsökning om 23 procent för fjärde kvartalet och ett ebita-resultat so...
Redeye comments on Lipigon’s successful identification of new small molecules that activate lipoprot...
Today, Idogen reported receiving approval from the Swedish Medical Products Agency for its phase l/l...
Metacon är ett energiteknikbolag med produkter som adresserar den växande vätgasmarkanden, som efter...
Lipigon uppnådde nyligen en viktig milstolpe efter att klinisk prövningsansökan med Lipisense inskic...
On 18 March, Cibus announced the terms of the class D share bonus issue.
Huvudägaren Stena Adactums budpliktsbud på 50 kronor per aktie i Svedbergs framstår i våra ögon som ...
Redeye states that last night’s oral hearing involved reinstated hope in surviving the ‘993 IPR thro...
We give a brief comment on the new clinical study with Vicore’s C21.
Redeye endorses ISAB signing yet another IRS contract worth around SEK 773,000 (EUR 74,000).
Flexion Mobile ökar omsättningen och lönsamheten under året.
Redeye leaves its Base Case unchanged following Infracom’s Q4 report, implying significant upside po...
Redeye raises its Base Case and forecasts following a Q4 report beating our estimates.
Redeye comments on Energy Save’s Q3’21/22 report. The report showed strong growth and profitability ...
Redeye ceases its coverage of Kebni due to the end of the contractual period.
Scandinavian Medical Solutions A/S (“SMS” or the “Company”) is a broker, specialized in the purchase...
SameSystem (“SameSystem” or the “Company”) is a Danish work-force management company “WFM”, the Comp...
Carbiotix AB (”Carbiotix” eller ”Bolaget”) tar fortsatta kliv mot sin bredare kommersiella fas där n...
Adverty enters into an exclusive agreement with Super League Gaming and gains access to more than 15...
Redeye gives a short comment on the announced rights issue of approximately SEK 150m.
